tiprankstipranks
CanSino Biologics, Inc. Class H (HK:6185)
:6185
Hong Kong Market
6185
CanSino Biologics, Inc. Class H
RESEARCH TOOLSreports
Want to see HK:6185 full AI Analyst Report?

CanSino Biologics, Inc. Class H (6185) Ratios

6 Followers

CanSino Biologics, Inc. Class H Ratios

HK:6185's free cash flow for Q1 2026 was ¥0.81. For the 2026 fiscal year, HK:6185's free cash flow was decreased by ¥ and operating cash flow was ¥-0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.11 3.55 2.42 2.00 2.63
Quick Ratio
 3.66 3.23 2.26 1.86 2.40
Cash Ratio
 1.25 1.14 0.88 0.79 1.15
Solvency Ratio
 0.07 0.10 -0.05 -0.30 -0.17
Operating Cash Flow Ratio
 0.08 0.03 -0.10 -0.35 -0.64
Short-Term Operating Cash Flow Coverage
 0.34 0.10 -0.19 -0.66 -1.20
Net Current Asset Value
¥ 1.63B¥ 1.79B¥ 1.23B¥ 1.15B¥ 3.51B
Leverage Ratios
Debt-to-Assets Ratio
 0.17 0.18 0.25 0.29 0.24
Debt-to-Equity Ratio
 0.24 0.26 0.41 0.51 0.40
Debt-to-Capital Ratio
 0.19 0.21 0.29 0.34 0.29
Long-Term Debt-to-Capital Ratio
 0.16 0.16 0.18 0.17 0.12
Financial Leverage Ratio
 1.42 1.45 1.62 1.77 1.70
Debt Service Coverage Ratio
 0.54 0.18 -0.14 -1.12 -0.68
Interest Coverage Ratio
 -0.05 -2.03 -6.26 -31.73 -33.11
Debt to Market Cap
 0.10 0.16 0.27 0.49 0.17
Interest Debt Per Share
 4.84 5.31 8.37 11.20 11.10
Net Debt to EBITDA
 0.30 0.87 -3.39 -0.40 0.53
Profitability Margins
Gross Profit Margin
98.88%66.07%71.12%-253.78%-18.10%
EBIT Margin
-0.34%-10.96%-44.33%-554.70%-145.39%
EBITDA Margin
12.06%5.91%-15.93%-476.76%-127.91%
Operating Profit Margin
-0.16%-10.96%-44.33%-589.60%-132.75%
Pretax Profit Margin
0.35%2.05%-45.04%-573.29%-114.84%
Net Profit Margin
-0.09%2.63%-44.77%-429.55%-88.21%
Continuous Operations Profit Margin
-0.09%2.63%-45.33%-569.97%-93.57%
Net Income Per EBT
-25.45%128.22%99.39%74.93%76.81%
EBT Per EBIT
-224.72%-18.72%101.59%97.23%86.50%
Return on Assets (ROA)
-0.01%0.38%-4.76%-15.91%-7.93%
Return on Equity (ROE)
-0.02%0.55%-7.72%-28.11%-13.48%
Return on Capital Employed (ROCE)
-0.03%-1.85%-6.07%-30.25%-16.05%
Return on Invested Capital (ROIC)
<0.01%-1.76%-5.29%-24.72%-10.99%
Return on Tangible Assets
-0.02%0.39%-4.93%-16.27%-8.11%
Earnings Yield
>-0.01%0.34%-5.17%-29.34%-6.25%
Efficiency Ratios
Receivables Turnover
 1.37 1.30 1.07 0.50 1.21
Payables Turnover
 5.25 6.94 3.91 11.75 4.81
Inventory Turnover
 0.70 1.03 0.87 3.46 1.80
Fixed Asset Turnover
 0.43 0.38 0.32 0.11 0.33
Asset Turnover
 0.16 0.14 0.11 0.04 0.09
Working Capital Turnover Ratio
 0.40 0.39 0.33 0.09 0.18
Cash Conversion Cycle
 720.07 580.69 667.73 811.21 430.15
Days of Sales Outstanding
 267.24 280.49 342.13 736.82 302.85
Days of Inventory Outstanding
 522.41 352.80 418.89 105.46 203.17
Days of Payables Outstanding
 69.58 52.60 93.29 31.08 75.87
Operating Cycle
 789.65 633.29 761.02 842.28 506.02
Cash Flow Ratios
Operating Cash Flow Per Share
 0.29 0.13 -0.68 -3.71 -7.64
Free Cash Flow Per Share
 -0.55 -0.60 -2.53 -6.19 -11.99
CapEx Per Share
 0.84 0.73 1.85 2.47 4.35
Free Cash Flow to Operating Cash Flow
 -1.91 -4.70 3.71 1.67 1.57
Dividend Paid and CapEx Coverage Ratio
 0.31 0.18 -0.32 -1.49 -1.49
Capital Expenditure Coverage Ratio
 0.34 0.18 -0.37 -1.50 -1.76
Operating Cash Flow Coverage Ratio
 0.06 0.03 -0.08 -0.34 -0.70
Operating Cash Flow to Sales Ratio
 0.06 0.03 -0.20 -2.65 -1.83
Free Cash Flow Yield
-1.21%-1.92%-8.55%-30.21%-20.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -15.10K 292.71 -19.34 -3.41 -16.01
Price-to-Sales (P/S) Ratio
 10.02 7.70 8.66 14.64 14.12
Price-to-Book (P/B) Ratio
 3.08 1.60 1.49 0.96 2.16
Price-to-Free Cash Flow (P/FCF) Ratio
 -82.36 -52.00 -11.70 -3.31 -4.91
Price-to-Operating Cash Flow Ratio
 213.27 244.64 -43.41 -5.52 -7.71
Price-to-Earnings Growth (PEG) Ratio
 532.07 -2.73 0.26 -0.05 0.11
Price-to-Fair Value
 3.08 1.60 1.49 0.96 2.16
Enterprise Value Multiple
 83.35 131.20 -57.72 -3.47 -10.51
Enterprise Value
 11.27B 8.00B 7.78B 5.71B 13.87B
EV to EBITDA
 83.35 131.20 -57.72 -3.47 -10.51
EV to Sales
 10.06 7.75 9.20 16.53 13.45
EV to Free Cash Flow
 -82.66 -52.35 -12.42 -3.74 -4.68
EV to Operating Cash Flow
 158.20 246.27 -46.11 -6.23 -7.35
Tangible Book Value Per Share
 18.67 19.37 18.73 20.59 28.28
Shareholders’ Equity Per Share
 19.94 19.56 19.83 21.37 27.32
Tax and Other Ratios
Effective Tax Rate
 1.25 -0.28 >-0.01 <0.01 0.19
Revenue Per Share
 4.54 4.07 3.42 1.40 4.17
Net Income Per Share
 >-0.01 0.11 -1.53 -6.01 -3.68
Tax Burden
 -0.25 1.28 0.99 0.75 0.77
Interest Burden
 -1.03 -0.19 1.02 1.03 0.79
Research & Development to Revenue
 0.40 0.00 0.49 1.85 0.75
SG&A to Revenue
 0.72 0.00 0.67 0.85 0.27
Stock-Based Compensation to Revenue
 <0.01 0.00 0.00 0.03 <0.01
Income Quality
 -70.82 1.20 0.44 0.62 1.59
Currency in CNY